News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bilenker Joshua H.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Bilenker Joshua H. (Director) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Granted 65,000 options to buy
@ $6.7, valued at
$435.5k
|
|
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Bilenker Joshua H. (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 23,500 options to buy
@ $8.97, valued at
$210.8k
|
|
| 02/18/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/18/2020 |
4
| Bilenker Joshua H. (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 23,500 options to buy
@ $12.1, valued at
$284.4k
|
|
| 06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/17/2019 |
4/A
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Exercised 7,500 shares
@ $1.184, valued at
$8.9k
|
|
| 01/02/2019 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 128,000 options to buy
@ $139.77, valued at
$17.9M
|
|
| 12/12/2018 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 969 shares
@ $130.58, valued at
$126.5k
Sold 2,001 shares
@ $132.09, valued at
$264.3k
Sold 2,104 shares
@ $133, valued at
$279.8k
Sold 2,049 shares
@ $134.31, valued at
$275.2k
Sold 2,377 shares
@ $135.04, valued at
$321k
Sold 400 shares
@ $136.48, valued at
$54.6k
Sold 100 shares
@ $137.39, valued at
$13.7k
Sold 647 shares
@ $134.63, valued at
$87.1k
Sold 1,153 shares
@ $135.76, valued at
$156.5k
Sold 3,393 shares
@ $136.79, valued at
$464.1k
Sold 2,407 shares
@ $137.63, valued at
$331.3k
|
|
| 11/28/2018 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 2,638 shares
@ $138.94, valued at
$366.5k
Sold 700 shares
@ $140.14, valued at
$98.1k
Sold 690 shares
@ $141.48, valued at
$97.6k
Sold 634 shares
@ $142.45, valued at
$90.3k
Sold 859 shares
@ $143.35, valued at
$123.1k
Sold 700 shares
@ $144.61, valued at
$101.2k
Sold 600 shares
@ $147.09, valued at
$88.3k
Sold 250 shares
@ $148.06, valued at
$37k
Sold 400 shares
@ $149.25, valued at
$59.7k
Sold 200 shares
@ $151.56, valued at
$30.3k
Exercised 29,000 options to buy
@ $1.184, valued at
$34.3k
|
|
| 10/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2018 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 700 shares
@ $164.1594, valued at
$114.9k
Sold 3,700 shares
@ $165.1821, valued at
$611.2k
Sold 2,400 shares
@ $166.4875, valued at
$399.6k
Sold 1,800 shares
@ $167.3814, valued at
$301.3k
Sold 800 shares
@ $168.5125, valued at
$134.8k
Sold 200 shares
@ $169.8872, valued at
$34k
Sold 400 shares
@ $171.075, valued at
$68.4k
Sold 5,636 shares
@ $165.425, valued at
$932.3k
Sold 3,402 shares
@ $166.523, valued at
$566.5k
Sold 962 shares
@ $167.3169, valued at
$161k
Exercised 10,000 options to buy
@ $1.184, valued at
$11.8k
|
|
| 08/15/2018 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,600 shares
@ $157.6677, valued at
$252.3k
Sold 4,233 shares
@ $158.5098, valued at
$671k
Sold 3,367 shares
@ $159.6267, valued at
$537.5k
Sold 800 shares
@ $160.4862, valued at
$128.4k
Sold 1,600 shares
@ $159.1263, valued at
$254.6k
Sold 7,100 shares
@ $159.9311, valued at
$1.1M
Sold 1,300 shares
@ $160.7508, valued at
$209k
Exercised 10,000 options to buy
@ $1.184, valued at
$11.8k
Exercised 10,000 options to buy
@ $1.184, valued at
$11.8k
|
|
| 07/11/2018 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 900 shares
@ $184.8698, valued at
$166.4k
Sold 1,500 shares
@ $186.3849, valued at
$279.6k
Sold 3,698 shares
@ $187.3871, valued at
$693k
Sold 802 shares
@ $188.2849, valued at
$151k
Sold 300 shares
@ $189.43, valued at
$56.8k
Sold 300 shares
@ $191.6333, valued at
$57.5k
Sold 2,200 shares
@ $178.1923, valued at
$392k
Sold 2,200 shares
@ $179.0809, valued at
$394k
Sold 1,000 shares
@ $180.081, valued at
$180.1k
Sold 1,300 shares
@ $181.2077, valued at
$235.6k
Sold 800 shares
@ $182.8388, valued at
$146.3k
|
|
| 06/21/2018 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Gifted 5,000 shares
@ $0
Sold 2,336 shares
@ $176.2016, valued at
$411.6k
Sold 3,427 shares
@ $177.0556, valued at
$606.8k
Sold 1,737 shares
@ $178.1172, valued at
$309.4k
Sold 8,232 shares
@ $177.4359, valued at
$1.5M
Sold 8,763 shares
@ $178.297, valued at
$1.6M
Sold 3,902 shares
@ $179.8333, valued at
$701.7k
Sold 103 shares
@ $180.3368, valued at
$18.6k
Sold 2,700 shares
@ $178.8052, valued at
$482.8k
Sold 4,370 shares
@ $179.3697, valued at
$783.8k
Sold 430 shares
@ $180.8965, valued at
$77.8k
|
|
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2018 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,717 shares
@ $129.3516, valued at
$222.1k
Sold 1,283 shares
@ $130.6232, valued at
$167.6k
Sold 1,500 shares
@ $131.7567, valued at
$197.6k
Sold 2,490 shares
@ $132.5426, valued at
$330k
Sold 510 shares
@ $133.4851, valued at
$68.1k
Sold 800 shares
@ $128.3045, valued at
$102.6k
Sold 800 shares
@ $129.4438, valued at
$103.6k
Sold 2,400 shares
@ $130.7121, valued at
$313.7k
Sold 3,400 shares
@ $131.8418, valued at
$448.3k
Sold 100 shares
@ $132.53, valued at
$13.3k
Exercised 7,500 options to buy
@ $1.184, valued at
$8.9k
|
|
| 03/15/2018 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 300 shares
@ $128.5733, valued at
$38.6k
Sold 1,100 shares
@ $129.9665, valued at
$143k
Sold 1,800 shares
@ $130.6906, valued at
$235.2k
Sold 1,715 shares
@ $131.7597, valued at
$226k
Sold 1,094 shares
@ $132.5781, valued at
$145k
Sold 1,491 shares
@ $133.5044, valued at
$199.1k
Sold 1,800 shares
@ $130.6584, valued at
$235.2k
Sold 4,300 shares
@ $131.5983, valued at
$565.9k
Sold 1,400 shares
@ $132.255, valued at
$185.2k
Exercised 7,500 options to buy
@ $1.184, valued at
$8.9k
Exercised 7,500 options to buy
@ $1.184, valued at
$8.9k
|
|
| 02/14/2018 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,250 shares
@ $91.7623, valued at
$114.7k
Sold 1,207 shares
@ $92.6139, valued at
$111.8k
Sold 3,942 shares
@ $93.7701, valued at
$369.6k
Sold 1,101 shares
@ $94.6842, valued at
$104.2k
Sold 1,100 shares
@ $94.4445, valued at
$103.9k
Sold 413 shares
@ $96.4718, valued at
$39.8k
Sold 100 shares
@ $97.14, valued at
$9.7k
Sold 400 shares
@ $98.6225, valued at
$39.4k
Sold 791 shares
@ $100.3344, valued at
$79.4k
Sold 3,996 shares
@ $101.1888, valued at
$404.4k
Sold 700 shares
@ $102.2029, valued at
$71.5k
|
|
| 01/18/2018 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 2,919 shares
@ $86.4236, valued at
$252.3k
Sold 1,604 shares
@ $87.1245, valued at
$139.7k
Sold 600 shares
@ $88.7767, valued at
$53.3k
Sold 1,577 shares
@ $89.9387, valued at
$141.8k
Sold 800 shares
@ $90.4964, valued at
$72.4k
Sold 1,104 shares
@ $86.1929, valued at
$95.2k
Sold 1,042 shares
@ $87.1416, valued at
$90.8k
Sold 2,672 shares
@ $88.8921, valued at
$237.5k
Sold 2,682 shares
@ $89.5249, valued at
$240.1k
Exercised 7,500 options to buy
@ $1.184, valued at
$8.9k
Exercised 7,500 options to buy
@ $1.184, valued at
$8.9k
|
|
| 01/05/2018 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 300,000 options to buy
@ $84.88, valued at
$25.5M
|
|
| 12/18/2017 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 2,600 shares
@ $82.5465, valued at
$214.6k
Sold 2,900 shares
@ $83.4179, valued at
$241.9k
Sold 2,000 shares
@ $84.2935, valued at
$168.6k
Sold 700 shares
@ $76.9271, valued at
$53.8k
Sold 2,268 shares
@ $78.0645, valued at
$177.1k
Sold 3,023 shares
@ $78.9932, valued at
$238.8k
Sold 609 shares
@ $80.0822, valued at
$48.8k
Sold 600 shares
@ $80.8817, valued at
$48.5k
Sold 100 shares
@ $81.72, valued at
$8.2k
Sold 200 shares
@ $82.86, valued at
$16.6k
Exercised 7,500 options to buy
@ $1.184, valued at
$8.9k
|
|
| 11/29/2017 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Gifted 6,000 shares
@ $0
Sold 4,693 shares
@ $74.1302, valued at
$347.9k
Sold 1,601 shares
@ $74.9838, valued at
$120k
Sold 906 shares
@ $76.1989, valued at
$69k
Sold 300 shares
@ $77.0733, valued at
$23.1k
Sold 2,400 shares
@ $73.1513, valued at
$175.6k
Sold 2,460 shares
@ $73.9936, valued at
$182k
Sold 1,850 shares
@ $75.2095, valued at
$139.1k
Sold 790 shares
@ $75.8524, valued at
$59.9k
Exercised 7,500 options to buy
@ $1.184, valued at
$8.9k
Exercised 7,500 options to buy
@ $1.184, valued at
$8.9k
|
|
| 11/01/2017 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 5,690 shares
@ $86.8752, valued at
$494.3k
Sold 998 shares
@ $87.7386, valued at
$87.6k
Sold 812 shares
@ $88.7737, valued at
$72.1k
Sold 2,961 shares
@ $86.1788, valued at
$255.2k
Sold 4,339 shares
@ $86.6545, valued at
$376k
Sold 200 shares
@ $87.665, valued at
$17.5k
Exercised 7,500 options to buy
@ $1.184, valued at
$8.9k
Exercised 7,500 options to buy
@ $1.184, valued at
$8.9k
|
|
| 09/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2017 |
4
| Bilenker Joshua H. (President & CEO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 100,000 options to buy
@ $43.56, valued at
$4.4M
|
|
| 12/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/15/2016 |
4
| Bilenker Joshua H. (10% Owner) has filed a Form 4 on ViewRay, Inc.|
Txns:
| Granted 18,964 shares
@ $0 |
|
|
|